liver neoplasm
Conditions
Interventions
group M:milrinone
Sponsors
second affiliated hospital of guangzhou medical university
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: patients aged 18~65 yr, ASA class I~III, Child-Pugh class A or B were recruited.
Exclusion criteria
Exclusion criteria: patients with previous cardiopulmonary and renal insufficiency, hepatocirrhosis, stroke, coagulation disturbance, severe arrhythmia, severe anemia, previous liver operation, milrinone or nitroglycerin allergy were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood loss;CI;CVP;right ventricular ejection fraction;norepinephrine dosage;serum lactate; | — |
Secondary
| Measure | Time frame |
|---|---|
| AST;ALT;SCr;hospital stay;postoperative complications; | — |
Countries
China
Contacts
Public ContactWudian Sheng
The Second Affiliated Hospital of Guangzhou Medical University
Outcome results
None listed